Trivalent chromium in glucose metabolism (commonly referred as Chromium(III)) (Cr(III))

Chromium(III) is an essential trace element that plays a supportive role in human glucose metabolism by enhancing insulin signaling and facilitating cellular glucose uptake. Chromium acts indirectly; it does not itself function as a receptor, enzyme, or transporter. Instead, it boosts the effectiveness of insulin, increases translocation of GLUT4 transporters to the cell membrane, and modulates cholesterol content and mitochondrial ATP synthase activity. Some studies suggest benefits for individuals with impaired glucose tolerance or type 2 diabetes, though clinical evidence is mixed and population-specific[1][2][3][4][5][6][7]. Chromium is not a drug target in the conventional sense but is frequently studied and supplemented for its metabolic effects.

Other names

Chromium(III)Trivalent chromiumCr3+Chromium picolinate (form used in supplements)Glucose tolerance factor (complexed form, debated)[5][6][7]

Potentiates insulin receptor signaling (by increased insulin receptor kinase activity via chromodulin binding)[5]; Augments GLUT4 translocation to the cell membrane, increasing glucose uptake into cells[1][2][3][4]; Lowers membrane cholesterol, increasing membrane fluidity and transporter mobilization[1][2][3]; Attenuation of negative regulators in insulin signaling (e.g., inhibition of PTP-1B, reduction of ER stress/JNK activity)[2][3]; Direct binding and modulation of mitochondrial ATP synthase, suppresses ATP5B activity, and upregulates glycolysis enzymes[6]